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Transient global amnesia (TGA), a disorder characterized by the acute onset of anterograde and retro-
grade amnesia, is well known to neurologists and has been reported in association with a wide range of
triggers. We report a patient who experienced the onset of TGA during pulmonary function testing.
Potential mechanisms and other scenarios provoking TGA relevant to the pulmonologist, such as
bronchoscopy, exercise testing, high altitude, and the use of phosphodiesterase inhibitors are discussed.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Transient global amnesia (TGA) is an uncommon neurological
disorder, consisting of the acute onset of anterograde and retro-
grade amnesia that resolves within 24 h.1 There is increasing
recognition of potential triggers for TGA, including circumstances
relevant to pulmonologists, which may help to elucidate its
underlying pathophysiology. Here we present a patient who
developed TGA during pulmonary function testing (PFT).
2. Case report
A 60 year old woman with a past medical history of hyperten-
sion, depression, and migraine without aura consulted with a pul-
monologist for a 1 year history of unexplained cough. She was not
a smoker and had no history of asthma or gastroesophageal reﬂux.
After a normal physical examination and chest radiography, she
was referred for PFT. Immediately after the ﬁrst few breaths of
spirometry, she became acutely confused. She appeared calm, but
stopped breathing into the mask, asking questions repeatedly such
as, ‘‘Where am I?’’ ‘‘What is going on?’’ She denied headache and
dyspnea, and was immediately taken to the emergency room.
Upon arrival, she was afebrile, had normal vital signs, and an
unremarkable physical examination. She was lucent, recognized
her husband, followed complex requests, and recalled all of theg; PFT, pulmonary function
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rved.prior evening’s activities. Despite repeated explanations of her
current circumstances, she continued to question where she was
and what was happening. Her neurological examination was
otherwise normal. Computed tomography of the brain, electrocar-
diogram, serum chemistry, complete blood count, liver function
and thyroid function tests were all normal. Brain magnetic reso-
nance imaging (MRI) was deferred because of claustrophobia. Over
several hours the patient gradually returned to normal, although
she remained permanently amnestic for an 8 h block of time that
day. Five years have elapsed since experiencing TGA and the patient
has had no recurrence.3. Discussion
This patient experienced the acute onset of a transient distur-
bance of strictly episodic memory, which was typical of TGA. The
notable feature in this patient was the onset of symptoms during
PFT. Precipitating events, most commonly emotional stress, phys-
ical exertion, and abrupt temperature change, may occur in 26–65%
of patients presenting with TGA.1
The annual incidence of TGA is 5–11 per 100,000 persons.1 The
pathogenesis of TGA is unknown, with putative etiologies related to
cerebral arterial ischemia, venous congestion, seizures, migraine,
and psychological stressors. 11–84% of TGA patients have MRI
diffusion-weighted imaging lesions (possibly signaling ischemia) in
the mesiotemporal lobe, which localizes well to the hippocampus,
the site of episodic memory formation and consolidation. However,
even in individuals with these MRI lesions, arterial ischemia is
doubtful because they do not have an increased vascular risk proﬁle
and their MRI show no evidence of other ischemic brain changes.2
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congestion. Internal jugular venous insufﬁciency may allow for
increased venous pressure to be transmitted during Valsalva
maneuver, causing ischemia to the hippocampus by venous
congestion. Patients with TGA are more likely than controls to have
jugular venous insufﬁciency or reﬂux during Valsalva when
measured by duplex ultrasonography, with retrograde ﬂow
patterns.1 Our patient may have had vulnerability because of
underlying venous insufﬁciency. After forced exhalations during
PFT, an acute escalation of intrathoracic pressure likely occurred,
causing jugular and intracranial venous congestion, and hippo-
campal ischemia. Alternatively, the stress of a medical test was
a trigger for TGA. A migrainous etiology is doubtful as the patient
experienced no headache, never had aura, and had no long-term
recurrence.
TGA occurring in PFT has been reported in 1 other patient, but
the speciﬁc details were not published.3 Other triggers relevant to
the pulmonologist include bronchoscopy, incremental exercise
testing, and high altitude.4–6 The use of the phosphodiesterase
inhibitors sildenaﬁl and tadafalil for erectile dysfunction has been
associated with cases of TGA.7 The mechanism of action may be
secondary to the production of nitric oxide donors, which can
precipitate migraine. Alternatively, sexual intercourse may increase
sympathetic tone, venous return, and lead to higher spikes of
venous pressure during Valsalva maneuvers. TGA has not been
reported following the use of these medications for pulmonary
hypertension.
TGA is a well-known disorder to neurologists but is less recog-
nized by other physicians, such as pulmonologists, who may be the
ﬁrst to encounter it as a complication of a procedure or medication.
TGA, with its heterogeneous set of triggering events, may have
a multifactorial etiology, and increasing recognition will only help
to enhance its understanding.Conﬂicts of interest
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